← FDA DRUG APPROVALS

FDA ANDA · ANDA088143

TRIFLUOPERAZINE HYDROCHLORIDE

Sponsor: WOCKHARDT

APPLICATION
ANDA088143
TYPE
ANDA
ORIGINAL APPROVAL
1983-07-26
LATEST ACTION
1992-04-17
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

TRIFLUOPERAZINE HYDROCHLORIDEDiscontinued
TRIFLUOPERAZINE HYDROCHLORIDE EQ 10MG BASE/ML · CONCENTRATE · ORAL

Approval history

1992-04-17Labeling · Supplement 10AP
1989-09-15Labeling · Supplement 9AP
1987-05-18Manufacturing (CMC) · Supplement 3AP
1987-05-18Manufacturing (CMC) · Supplement 4AP
1983-07-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →